#ScienceNews #NovoNordiskFoundation #Alzheimers #Parkinsons #PrecisionMedicine #Metabolism #Neurology #MedicalResearch To view or add a comment, sign in Im happy to share our latest research: Alcohol-fluoxetine co-treatment drives gut dysbiosis and intestinal barrier disruption with consequences for neuroimmune signaling in male rats. Alcohol use disorder and depression frequently coexist, yet little is known about how alcohol and antidepressant treatment interact through the gut-brain axis
The Medicines and Healthcare products Regulatory Agency (MHRA) said the trend had only just emerged, leading them to conduct the largest single seizure of trafficked weight-loss drugs ever recorded by any global law enforcement agency
Allergan Aesthetics, the owner of CoolSculpting, reports that PAH occurs in about 0.033% of treatments (1 in 3,000), though some sources suggest the incidence may be higher
Carotenoids and Alzheimers disease: an insight into therapeutic role of retinoids in animal models
For example, the lowest dose studied and approved for Zepbound (tirzepatide) is 2.5 mg